Les statines : nouvelles propriétés
Authors:
- Pierre AmbrosiPAPierre Ambrosi
- Patrick VillaniPVPatrick Villani
- Gilbert HabibGHGilbert Habib
- Gilles BouvenotGBGilles Bouvenot
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 DiabetesArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Why some patients respond poorly to statins and how this might be remediedEuropean Heart Journal, 2002
- Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase InhibitorsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Vascular inflammation and activation: new targets for lipid lowering*1European Heart Journal Supplements, 2001
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stabilityCardiovascular Research, 2000
- Pravastatin and Coronary Heart DiseaseCirculation, 1998
- Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 1998
- Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic MonkeysJACC, 1998
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995